Bill Text: TX HB4082 | 2017-2018 | 85th Legislature | Introduced
Bill Title: Relating to the practice of therapeutic optometry.
Spectrum: Partisan Bill (Republican 1-0)
Status: (Introduced - Dead) 2017-04-03 - Referred to Public Health [HB4082 Detail]
Download: Texas-2017-HB4082-Introduced.html
85R9085 KKR-F | ||
By: Zedler | H.B. No. 4082 |
|
||
|
||
relating to the practice of therapeutic optometry. | ||
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | ||
SECTION 1. Sections 351.358(b), (c), (d), and (e), | ||
Occupations Code, are amended to read as follows: | ||
(b) A therapeutic optometrist may: | ||
(1) administer, perform, or prescribe ophthalmic | ||
devices, procedures, and appropriate medications administered by | ||
topical or oral means[ |
||
|
||
conditions, or diseases of the human vision system, including the | ||
eye and adnexa; or | ||
(2) administer medication by parenteral means for a | ||
purpose and in a manner prescribed by Subsection (d) [ |
||
(c) A therapeutic optometrist may administer or prescribe | ||
oral analgesics [ |
||
classifications of oral pharmaceuticals: | ||
(1) [ |
||
[ |
||
[ |
||
|
||
[ |
||
as a controlled substance under Schedule [ |
||
III, IV, or [ |
||
(2) one three-day supply of hydrocodone or of a | ||
hydrocodone combination product classified as a controlled | ||
substance under Schedule II of 21 U.S.C. Section 812 | ||
[ |
||
|
||
|
||
(d) [ |
||
|
||
|
||
[ |
||
medication for a patient who has an anaphylactic reaction to | ||
counteract the anaphylaxis. The therapeutic optometrist shall | ||
immediately refer the patient to a physician. | ||
SECTION 2. Section 351.3581, Occupations Code, is amended | ||
to read as follows: | ||
Sec. 351.3581. [ |
||
[ |
||
oral or parenteral medication or treat glaucoma unless the | ||
therapeutic optometrist holds a certificate issued by the board. A | ||
therapeutic optometrist certified under this section [ |
||
shall be known as an optometric glaucoma specialist. To obtain a | ||
certificate, a therapeutic optometrist must [ |
||
|
||
(1) complete an instructional clinical review course; | ||
and | ||
(2) pass an examination approved by the board. | ||
[ |
||
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
||
[ |
||
|
||
|
||
|
||
|
||
|
||
|
||
[ |
||
|
||
[ |
||
|
||
[ |
||
|
||
[ |
||
|
||
[ |
||
|
||
|
||
|
||
|
||
|
||
[ |
||
|
||
|
||
|
||
|
||
|
||
[ |
||
|
||
|
||
|
||
|
||
[ |
||
|
||
|
||
|
||
|
||
|
||
[ |
||
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
||
[ |
||
|
||
|
||
|
||
[ |
||
|
||
[ |
||
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
||
SECTION 3. This Act takes effect September 1, 2017. |